Veeco Receives Order for TurboDisc K465 GaN MOCVD Systems from Bridgelux

Veeco Instruments Inc. (Nasdaq: VECO), manufactures enabling solutions for customers in the HB-LED, solar, data storage, semiconductor, scientific research and industrial mark, announced today that Bridgelux, Inc., a U.S. lighting company and leading supplier of energy-saving light-emitting diode (LED)-based light sources, has placed a multi-unit order for Veeco's TurboDisc® K465™ gallium nitride (GaN) Metal Organic Chemical Vapor Deposition (MOCVD) systems to support its production ramp.

“Bridgelux is focused on enabling mass adoption of LED-based solid-state lighting by reducing the cost of light for the general lighting market,” stated Mark Swoboda, Bridgelux Chief Executive Officer. “Bridgelux is committed to the advancement of our core LED materials and process technologies. We expect Veeco to be a strategic partner for our manufacturing expansion.”

Bill Miller, Ph.D., Senior Vice President, General Manager of Veeco's MOCVD Operations, commented, “We are pleased to have been selected by Bridgelux to meet their production ramp for interior and exterior general illumination applications. Bridgelux is an important industry player, and we are very excited to secure this important new customer.”

The Veeco TurboDisc K465 GaN MOCVD System is the only production-proven, fully automated MOCVD platform available on the market today. The "K-Series" MOCVD platform includes the K465 for GaN LED applications and the K475 for arsenic phosphide (As/P) LED and solar applications. These fully-automated platforms have demonstrated high productivity and reduced cost of ownership in the industry’s latest volume production fabs.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.